
NYSE:UN
This summary was created by AI, based on 1 opinions in the last 12 months.
Unilever NV has recently come under scrutiny as analysts highlight notable challenges affecting its performance and strategy. The stock was labeled a top pick by some experts on June 2, 2025, despite having lost 4% of its value recently. Key concerns include a significant shift in consumer dietary preferences driven by the rise of GLP-1 medications, leading to a decline in the consumption of processed foods typically produced by Unilever. Additionally, the company’s merger with McCormick has been described as disastrous, indicating possible missteps in corporate strategy and execution. Overall, there seems to be a growing concern regarding Unilever's focus and future growth prospects amidst these evolving market dynamics.
The book for this is effectively 50% emerging markets and 50% developed economies. The key driver in the last few years has been the emerging markets. What has offset that have been weaker currencies. Although the penetration, market share and economics have continued to improve, the relatively little profit coming back has been less. He is a firm believer that emerging markets are going to continue to grow. It will be lumpy growth.
A great story and not an expensive stock. Trading at about 17X earnings. Has a 4.2% dividend yield. What they has done, that a lot of other companies have not done, is to restructure their assets. They’ve looked at their brands and their global businesses and made some very structural changes that are very important.